Metraipolis › archive › dc_891997aff6dd

Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives — Europe PMC PMID:42358938

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42358938
DOI: 10.3389/fneur.2026.1813230
License (as archived): solo-consultazione
Archived: 2026-10-31T15:20:35.094Z
SHA-256 of the archived text: 418770e835ad5d18c5ba2fb14e2cb1d8e164b12058fc102f8b0718dd362e1b89
Stable URL of this page: https://metraipolis.com/documento/dc_891997aff6dd

How to cite

Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives — Europe PMC PMID:42358938 — Europe PMC (en), https://europepmc.org/article/MED/42358938 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_891997aff6dd (Metraipolis archive dc_891997aff6dd, sha256 418770e835ad5d18c5ba2fb14e2cb1d8e164b12058fc102f8b0718dd362e1b89)

BibTeX

@misc{dc891997aff6dd,
  title = {Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives — Europe PMC PMID:42358938},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358938},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_891997aff6dd; sha256 418770e835ad5d18c5ba2fb14e2cb1d8e164b12058fc102f8b0718dd362e1b89},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358938. Agents can read the archived copy with the MCP tool read_document.